Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency

NCT03008915 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT03008915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03008915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2017
Completion date
October 31, 2020
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alpha-1 antitrypsin deficiency, chronic obstructive pulmonary disease, emphysema